Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA And Industry Set Out GDUFA III Priorities
Focusing Initially On First-Cycle Approvals And Priority Assessment Improvements
Nov 04 2020
•
By
Derrick Gingery
GDUFA III negotiations include discussions of the pre-submission facility correspondence program, a prerequisite for a priority assessment. • Source: Shutterstock
More from Generics
More from Products